Rifamicina

Rifocin

Soluzione iniettabileItalyAuthorised

In other countries

The same active substances on other registers, the same brand first.

rifamicinaBrazil · Natulab Laboratorio S.ASame substance
RifotratBrazil · Natulab Laboratorio S.ASame substance
RifamicinaBrazil · Legrand Pharma Indústria Farmacêutica LtdaSame substance
Rifamicina Adalvo 200 MG Comprimidos de Liberacion ModificadaSpain · 200 mg · comprimido de liberación modificada · Adalvo Competence Center S.R.L.Same substance
AemcoloUnited States · 194MG BASE · tablet, delayed release · Cosmo TechnologiesSame substance

Packs

Pack	Code	Status
250 MG/3 ML SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE- 1 FIALA DA 3 ML	020009015	Autorizzata
250 MG/10 ML SOLUZIONE INIETTABILE PER USO ENDOVENOSO - 1 FIALA DA 10 ML	020009041	Autorizzata

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Rifamicina

Rifocin

Soluzione iniettabileItalyAuthorised

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
250 MG/3 ML SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE- 1 FIALA DA 3 ML	020009015	Autorizzata
250 MG/10 ML SOLUZIONE INIETTABILE PER USO ENDOVENOSO - 1 FIALA DA 10 ML	020009041	Autorizzata

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Rifamicina
Dosage form: Soluzione iniettabile
Register: Italy (AIFA)
Status: Authorised
Status in the register: Autorizzata
Registration: AIC 020009
Marketing authorisation holder: Sanofi S.R.L.
ATC code: J04AB03
Group: Anti-infectives for systemic use
Procedure: Procedura Nazionale
Supply: Medicinali soggetti a prescrizione medica